Skip to main content
SpringerLink
Log in

Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM)

  • Review
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schedel I. Application of immunoglobulin preparations in multiple myeloma. In: Morell A, Nydegger UE (eds).Clinical Use of Intravenous Immunoglobulins. Academic Press: London 1985, pp 123–132.

    Google Scholar 

  2. Sklenar Iet al. Effect of various doses of intravenous polyclonal IgG onin vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukemia and multiple myeloma.Oncology 1993;50: 466–477.

    Article  CAS  PubMed  Google Scholar 

  3. Hargreaves RMet al. Immunological factors and risk of infection in plateau phase myeloma.J Clin Pathol 1995;48: 260–206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gregersen Het al. The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance.Eur J Haematol 1998;61: 140–144.

    Article  CAS  PubMed  Google Scholar 

  5. Broder Set al. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma: Role of suppressor cells.N Engl J Med 1975;293: 887–892.

    Article  CAS  PubMed  Google Scholar 

  6. Kennard J, Zolla-Pazner S. Origin and function of suppressor macrophages in multiple myeloma.J Immunol 1980;24: 268–273.

    Article  Google Scholar 

  7. Farnen JP, Tyrkus M, Hanson CA, Cody RL, Emerson SG. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytesin vitro.Leukemia 1991;5: 574–584.

    CAS  PubMed  Google Scholar 

  8. Paglieroni T, Caggiano V, MacKenzie M. Abnormalities in immune regulation precede the development of multiple myeloma.Am J Hematol 1992;40: 51–55.

    Article  CAS  PubMed  Google Scholar 

  9. Carter A, Silivian I, Tatarsky I, Spira G. Impaired immunoglobulin synthesis in multiple myeloma: a B-cell dysfunction.Am J Hematol 1986;22: 143–154.

    Article  CAS  PubMed  Google Scholar 

  10. Sanderson RD, Lalor P, Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation.Cell Regulation 1989;1: 27–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Rawstron ACet al. B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.Br J Haematol 1998;100: 176–183.

    Article  CAS  PubMed  Google Scholar 

  12. Tsujimoto T, Lisukov LA, Huang N, Mahmoud MS, Kawano MM. Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells.Blood 1996;97: 3375–3383.

    Article  Google Scholar 

  13. Kay NEet al. Circulating blood B cells in multiple myeloma: Analysis of relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the eastern cooperative oncology group phase III E9486 clinical trial.Blood 1997;90: 340–345.

    Article  CAS  PubMed  Google Scholar 

  14. Munshi NC. Immunoregulatory mechanisms in multiple myeloma.Hemat Oncol Clin NA 1997;11: 51–69.

    Article  CAS  Google Scholar 

  15. Kawano Met al. Altered cytokine activities are related to the suppression of synthesis of normal immunoglobulin in multiple myeloma.Am J Hematol 1989;30: 91–96.

    Article  CAS  PubMed  Google Scholar 

  16. Kyrtsonis M-C, Dedoussis G, Baxevanis C, Stamatelou M, Maniatis A. Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM).Br J Haematol 1996;92: 420–422.

    Article  Google Scholar 

  17. Kyrstonis M-Cet al. Serum transforming growth factor-β1 is related to the degree of immunoparesis in patients with multiple myeloma.Med Oncol 1998;15: 124–128.

    Article  Google Scholar 

  18. Berg DJ, Lynch RG. Immune dysfunction in mice with plasmacytomas.J Immunol 1991;146: 2865–2872.

    Article  CAS  PubMed  Google Scholar 

  19. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. Growth inhibition by TGF-â linked to suppression of retinoblastoma protein phosphorylation.Cell 1990;62: 175–185.

    Article  CAS  PubMed  Google Scholar 

  20. Ng MHLet al. Frequent hypermethylation of p16 and p15 genes in multiple myeloma.Blood 1997;89: 2500–2506.

    Article  CAS  PubMed  Google Scholar 

  21. Lapena Pet al. Increased production of IL-6 by T lymphocytes from patients with multiple myeloma.Exp Hematol 1996;24: 26–30.

    CAS  PubMed  Google Scholar 

  22. Pilarski LMet al. Abnomal clonogenic potential of T cells from multiple myeloma patients.Blood 1985;66: 1266–1271.

    Article  CAS  PubMed  Google Scholar 

  23. Serra HM, Mant MJ, Ruether BA, Ledbetter JA, Pilarski LM, Slective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients.J Clin Immunol 1988;8: 259–265.

    Article  CAS  PubMed  Google Scholar 

  24. Dianzani Uet al. Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: Correlation with diagnosis and disease status.Blood 1988;78: 1064–1073.

    Article  Google Scholar 

  25. Massaia Met al. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients.Blood 1995;85: 3679–3687.

    Article  CAS  PubMed  Google Scholar 

  26. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: Increasing evidence for a multistep transformation process.Blood 1998;9: 3–21.

    Article  Google Scholar 

  27. Villunger Aet al. Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: A potential mechanism of tumor induced suppression of immune surveillance.Blood 1997;90: 12–20.

    Article  CAS  PubMed  Google Scholar 

  28. Waldmann TA, Strober W. Metabolism of immunoglobulins.Prog Allergy 1969;13: 1–110.

    CAS  PubMed  Google Scholar 

  29. Chapel HM, Lee M, Hargreaves R. Randomized trial of intravenous immunoglobulin as prophylaxis against infection in plateau phase multiple myeloma.Lancet 1994;343: 1059–1063.

    Article  CAS  PubMed  Google Scholar 

  30. Touncouz M, Denys CH, DeGroute D, Dupont E.In vitro inhibition of tumor necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulins.Br J Haematol 1995;89: 698–703.

    Article  Google Scholar 

  31. Ruiz de Souza Vet al. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin).Eur J Immunol 1995;25: 1267–1273.

    Article  CAS  PubMed  Google Scholar 

  32. Amran Det al. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin.Clin Immunol Immunopathol 1994;73: 180–186.

    Article  CAS  PubMed  Google Scholar 

  33. Hansen MB. Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors.Eur J Immunol 1995;25: 348–354.

    Article  CAS  PubMed  Google Scholar 

  34. Oken MM, Pomeroy C, Weisdort D, Bennett JM. Prophylactic antibiotics for the prevention of early infection in multiple myeloma.Am J Med 1996;100: 624–628.

    Article  CAS  PubMed  Google Scholar 

  35. Shustik Cet al. Glucocorticoid dose related susceptibility to infection in myeloma patients treated with melphalan.Blood 1997;90: 358a.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lab. for Hematology and Transfusion Medicine, University of Patras Medical School, GR-26110, Patras, Greece

    Maria-Christina Kyrtsonis, Athanasia Mouzaki & Alice Maniatis

Authors
  1. Maria-Christina Kyrtsonis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Athanasia Mouzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alice Maniatis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alice Maniatis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kyrtsonis, MC., Mouzaki, A. & Maniatis, A. Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM). Med Oncol 16, 73–77 (1999). https://doi.org/10.1007/BF02785839

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02785839

Keywords

Search

Navigation